Beta Bionics targets $695 million valuation in upsized US IPO
Beta Bionics is targeting a valuation of up to $695 million in an upsized initial public offering, the insulin delivery device maker said on Tuesday. The company will aim to raise up to $170 million ...
Alzinova AB: Alzinova strategically realigns CMO position to enhance collaboration and drive next development phase
Alzinova AB (publ) (ticker: ALZ) hereby announces that the Company's CMO is stepping down from her role after mutual agreement. The basis is a strategic decision to appoint a CMO in place at the Compa ...
If you live at this house number, your property could be 'cursed'
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Opinion Live Q&A: Behind Nvidia and Big Tech’s DeepSeek Panic
Application error: a client-side exception has occurred (see the browser console for more information).